Dr. Surana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 877-442-3324Fax+1 617-632-5370
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2016 - 2019
- Georgetown University School of MedicineClass of 2016
Certifications & Licensure
- MA State Medical License 2022 - 2026
- OR State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan
Clinical Cancer Research. 2024-11-01 - Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma
Cancer Immunology Research. 2024-09-03 - 1 citationsUtility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials.Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, David S Hong, Timothy A Yap
Journal of Gastrointestinal Cancer. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: